Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

NCT01570036 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Herceptin
DRUG: NeuVax vaccine
DRUG: GM-CSF

Sponsor

George E. Peoples

Collaborators

[object Object]
[object Object]